RenovoRx, Inc.

RNXTNASDAQHealthcare● Active

$0.90

+$0.02(+1.91%)

Market Cap$33595562

P/E Ratio—

52W High$1.45

52W Low$0.701

Avg Volume377K

Open$0.89

Beta1.00

Insider Trades Ownership Employees

RenovoRx, Inc. (RNXT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · RNXT · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

RenovoRx, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

RNXT insider buying and selling by quarter

RNXT insider selling · RNXT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.8M901K0

2023 Q4

2024 Q1

2024 Q4

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · RNXT ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

RNXT executive sell shares · RNXT board member insider trading · RNXT insider trading SEC filing

Showing 39 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 19, 2026	VOLL MARK CFO	Purchase	25,000	$0.79	$20K	142,380	Form 4
Apr 3, 2026	VOLL MARK CFO	Award	80,000	—	—	117,380	Form 4
Mar 25, 2026	VOLL MARK CFO	Award	12,380	—	—	37,380	Form 4
Mar 20, 2026	Marton Laurence Director	Purchase	9,720	—	—	9,720	Form 4
Mar 20, 2026	Bagai Shaun CEO · Director	Purchase	24,300	—	—	313,357	Form 4
Mar 20, 2026	VOLL MARK CFO	Purchase	97,200	—	—	97,200	Form 4
Jan 21, 2026	Agah Ramtin Chief Medical Officer · Director	Purchase	10,000	$1.00	$10K	798,460	Form 4
Dec 31, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	9,795	$0.86	$8K	788,460	Form 4
Dec 30, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	205	$0.83	$169	778,665	Form 4
Dec 18, 2025	Bagai Shaun CEO · Director	Purchase	5,000	$0.90	$5K	340,040	Form 4
Dec 17, 2025	Bagai Shaun CEO · Director	Purchase	5,000	$0.85	$4K	335,040	Form 4
Dec 16, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	12,000	$0.85	$10K	778,460	Form 4
Dec 5, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	10,000	$0.96	$10K	766,460	Form 4
Nov 24, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	12,000	$0.80	$10K	756,460	Form 4
Nov 21, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	10,000	$0.80	$8K	744,460	Form 4
Aug 25, 2025	Bagai Shaun CEO · Director	Purchase	5,000	$0.91	$5K	330,040	Form 4
Aug 22, 2025	Bagai Shaun CEO · Director	Purchase	5,000	$0.95	$5K	325,040	Form 4
Jun 5, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	21,000	$1.40	$29K	734,460	Form 4
Apr 22, 2025	Agah Ramtin Chief Medical Officer · Director	Gift	400,000	—	—	713,460	Form 4
May 2, 2025	Marton Laurence Director	Option	20,480	$0.15	$3K	66,164	Form 4
Apr 15, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	15,000	$0.90	$14K	1,113,460	Form 4
Apr 15, 2025	Bagai Shaun CEO · Director	Purchase	7,500	$0.91	$7K	320,040	Form 4
Apr 11, 2025	Agah Ramtin Chief Medical Officer · Director	Purchase	20,000	$0.80	$16K	1,098,460	Form 4
Apr 10, 2025	Kocak Ron VP Controller and PAO	Purchase	6,500	$0.79	$5K	12,595	Form 4
Apr 9, 2025	Kocak Ron VP Controller and PAO	Purchase	6,000	$0.80	$5K	6,095	Form 4

VOLL MARK

CFO

Purchase

Date

May 19

25,000

Price

$0.79

Value

$20K

View Form 4 on SEC.gov

VOLL MARK

CFO

Award

Date

Apr 3

80,000

Price

—

Value

—

View Form 4 on SEC.gov

VOLL MARK

CFO

Award

Date

Mar 25

12,380

Price

—

Value

—

View Form 4 on SEC.gov

Marton Laurence

Director

Purchase

Date

Mar 20

9,720

Price

—

Value

—

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

Date

Mar 20

24,300

Price

—

Value

—

View Form 4 on SEC.gov

VOLL MARK

CFO

Purchase

Date

Mar 20

97,200

Price

—

Value

—

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Jan 21

10,000

Price

$1.00

Value

$10K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Dec 31

9,795

Price

$0.86

Value

$8K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Dec 30

205

Price

$0.83

Value

$169

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

Date

Dec 18

5,000

Price

$0.90

Value

$5K

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

Date

Dec 17

5,000

Price

$0.85

Value

$4K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Dec 16

12,000

Price

$0.85

Value

$10K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Dec 5

10,000

Price

$0.96

Value

$10K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Nov 24

12,000

Price

$0.80

Value

$10K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Nov 21

10,000

Price

$0.80

Value

$8K

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

Date

Aug 25

5,000

Price

$0.91

Value

$5K

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

Date

Aug 22

5,000

Price

$0.95

Value

$5K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Jun 5

21,000

Price

$1.40

Value

$29K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Gift

Date

Apr 22

400,000

Price

—

Value

—

View Form 4 on SEC.gov

Marton Laurence

Director

Option

Date

May 2

20,480

Price

$0.15

Value

$3K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Apr 15

15,000

Price

$0.90

Value

$14K

View Form 4 on SEC.gov

Bagai Shaun

CEO · Director

Purchase

Date

Apr 15

7,500

Price

$0.91

Value

$7K

View Form 4 on SEC.gov

Agah Ramtin

Chief Medical Officer · Director

Purchase

Date

Apr 11

20,000

Price

$0.80

Value

$16K

View Form 4 on SEC.gov

Kocak Ron

VP Controller and PAO

Purchase

Date

Apr 10

6,500

Price

$0.79

Value

$5K

View Form 4 on SEC.gov

Kocak Ron

VP Controller and PAO

Purchase

Date

Apr 9

6,000

Price

$0.80

Value

$5K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About RNXT insider trading

RNXT insider trades

RenovoRx, Inc. (RNXT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Agah Ramtin (Chief Medical Officer · Director), Bagai Shaun (CEO · Director), VOLL MARK (CFO). Over the past 12 months, 4 insiders have filed transactions with the SEC. RNXT insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For RenovoRx, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

RNXT insider trading · 5 questions

The insiders of RenovoRx, Inc. (RNXT) include executives and directors such as Agah Ramtin (Chief Medical Officer · Director), Bagai Shaun (CEO · Director), VOLL MARK (CFO), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

RNXT board member insider tradingwho are RNXT insidersRNXT insider rosterRenovoRx, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026